These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
940 related items for PubMed ID: 16142041
1. Epidemiology and costs of diabetes treated with insulin in France. Detournay B, Raccah D, Cadilhac M, Eschwège E. Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041 [Abstract] [Full Text] [Related]
2. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]. Fabian W, Majkowska L, Stefański A, Moleda P. Przegl Lek; 2005 Jun; 62(4):201-5. PubMed ID: 16229234 [Abstract] [Full Text] [Related]
3. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study]. von Ferber L, Köster I, Hauner H. Med Klin (Munich); 2006 May 15; 101(5):384-93. PubMed ID: 16685485 [Abstract] [Full Text] [Related]
4. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T. Dtsch Med Wochenschr; 2009 Jun 15; 134(23):1207-13. PubMed ID: 19472091 [Abstract] [Full Text] [Related]
5. [Impact of demographic changes on drug utilization related to diabetes in Aquitaine]. Taboulet F, Latry P, Fontaine S, Timmerman L. Cah Sociol Demogr Med; 1999 Jun 15; 39(2-3):253-69. PubMed ID: 10615566 [Abstract] [Full Text] [Related]
10. [Epidemiology of diabetes in metropolitan France]. Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H. Diabetes Metab; 2000 Sep 15; 26 Suppl 6():11-24. PubMed ID: 11011236 [Abstract] [Full Text] [Related]
11. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study. Schöffski O, Breitscheidel L, Benter U, Dippel FW, Müller M, Volk M, Pfohl M. J Med Econ; 2008 Sep 15; 11(4):695-712. PubMed ID: 19450076 [Abstract] [Full Text] [Related]
13. [Cost of the treatments of arterial hypertension associated with diabetes]. Passa P, Giraud S. Diabete Metab; 1993 Dec 15; 19(5 Suppl):523-7. PubMed ID: 8206192 [Abstract] [Full Text] [Related]
16. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss. Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M. Curr Med Res Opin; 2005 Nov 15; 21(11):1885-90. PubMed ID: 16307710 [Abstract] [Full Text] [Related]
18. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Goldberg RB, Fonseca VA, Truitt KE, Jones MR. Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China. Palmer JL, Gibbs M, Scheijbeler HW, Kotchie RW, Nielsen S, White J, Valentine WJ. Adv Ther; 2008 Aug 28; 25(8):752-74. PubMed ID: 18704282 [Abstract] [Full Text] [Related]